Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2005
10/25/2005US6958480 forming an ordered nanocomposite surfactant thin film; surfactant removal; adsorption of sample; matrix-free laser desorption/ionization mass spectrometry; improved substrate strength and porosity
10/25/2005US6958390 Compositions and kits for herpes simplex virus type 1 and 2 nucleic acid detection
10/25/2005US6958386 MUM-1 protein expressed by multiple myeloma-related gene
10/25/2005US6958361 Drugs, vaccines
10/25/2005US6958245 Array cytometry
10/25/2005US6958240 Inhibition of major groove DNA binding proteins by modified polyamides
10/25/2005US6958231 Determination concentration of creatine, creatine in sample by generating hydrogen peroxide; calibrtaion
10/25/2005US6958225 Reduction of nucleotide sequence complexity of sample; obtain sample, incubate with enzymes, fragment sequences, ligate adaptors, amplify and recover sequences
10/25/2005US6958222 Methane or methanol as sole carbon source; Embden-Meyerhof carbon pathway comprising a gene encoding a pyrophosphate dependent phosphofructokinase; biomass contains protein, carbohydrates and pigment on industrial scale
10/25/2005US6958217 Purification of single stranded complementary nucleotide sequence probe; gene expression; restriction fragment length polymorphisms; diagnosis of genetic disorders
10/25/2005US6958216 DNA-bridged carbon nanotube arrays
10/25/2005US6958215 Methods and compositions for inhibition of RNA splicing
10/25/2005US6958214 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/25/2005US6958212 coupling of a pharmaceutically active compound to a polymer using a conjugate addition reaction, and the cross-linking of the polymer to form a biomaterial, in some embodiments using conjugate addition reactions; controlled release of drug
10/25/2005US6958211 Methods of assessing HIV integrase inhibitor therapy
10/25/2005US6958210 Detection of herpes simplex virus
10/25/2005US6958152 Human phospholipase C delta 5
10/25/2005US6958129 signal producing system indicative of glucose concentration, total protein concentration, and non-glycated protein in a whole blood sample; diabetes diagnosis
10/25/2005US6957733 Method and apparatus for document processing
10/25/2005CA2251673C Heteroduplex tracking assay (hta) for genotyping hcv
10/25/2005CA2192005C Rolling door made from interlocking thermoplastic panels
10/25/2005CA2137548C Morphinone reductase for the preparation of hydromorphone and hydrocodone
10/25/2005CA2105944C Detection of nucleic acids in blood
10/23/2005CA2503206A1 Extraction of nucleic acids using small diameter magnetically-responsive particles
10/23/2005CA2502549A1 Use of an extraction control in a method of extracting nucleic acids
10/20/2005WO2006121423A2 Nucleic acid melting analysis with saturation dyes
10/20/2005WO2005098449A2 Hausp-mdm2 interaction and uses thereof
10/20/2005WO2005098448A2 Method and biomarkers for detecting tumor endothelial cell proliferation
10/20/2005WO2005098442A2 Assay system and method for direct measurement of ldl cholesterol
10/20/2005WO2005098438A1 Analysis array comprising heatable electrodes, and methods for chemical and biochemical analysis
10/20/2005WO2005098431A1 Analyte test system for determining the concentration of an analyte in a physiological fluid
10/20/2005WO2005098427A2 Method, composition and device for treating starch related diseases
10/20/2005WO2005098424A1 Method and apparatus for implementing threshold based correction functions for biosensors
10/20/2005WO2005098422A2 Detecting recessive diseases in inbred populations
10/20/2005WO2005098421A2 Sensor for contaminants
10/20/2005WO2005098051A2 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides
10/20/2005WO2005098050A2 Base specific cleavage of methylation-specific amplification products in combination with mass analysis
10/20/2005WO2005098049A2 Hybridization chain reaction
10/20/2005WO2005098048A1 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents
10/20/2005WO2005098047A2 Compositions for use in identification of bacteria
10/20/2005WO2005098046A2 Methods for the determination of cell specific biomarkers
10/20/2005WO2005098045A1 Diagnosis of systemic lupus erythematosus
10/20/2005WO2005098044A1 Methods for amplification of nucleic acid sequences using promoter templates
10/20/2005WO2005098043A2 Ligand-dependent protein splicing
10/20/2005WO2005098042A2 Quantitative amplification with a labeled probe and 3' to 5' exonuclease activity
10/20/2005WO2005098041A2 Detection and treatment of fibrotic disorders
10/20/2005WO2005098040A2 Ligation and amplification reactions for determining target molecules
10/20/2005WO2005098039A2 Method and apparatus for analyzing and generating human antibody amino acid and nucleic acid sequences
10/20/2005WO2005098038A2 Use of rna polymerase as an information-dependent molecular motor
10/20/2005WO2005098037A1 Breast cancer signatures
10/20/2005WO2005098036A1 Oligonucleotide for detecting target dna or rna
10/20/2005WO2005098035A2 Method for the quantification of methylated dna
10/20/2005WO2005098034A1 Ercc2 polymorphisms
10/20/2005WO2005098033A1 Screening method for identifying pufa pks in samples
10/20/2005WO2005098032A1 Method of diagnosing osseointegration of artificial dental implants by means of gene arrays
10/20/2005WO2005098031A1 Liquid-based hybridization assay
10/20/2005WO2005098030A2 Method for the identification of fungicidally-effective compounds based on thioredoxin reductases
10/20/2005WO2005098029A2 Methods for quantification of micrornas and small interfering rnas
10/20/2005WO2005098028A1 Neisseria gonorrhoeae detection
10/20/2005WO2005098027A1 Combination therapies with epothilones and carboplatin
10/20/2005WO2005098026A1 Method of determining carbonic anhydrase i activity
10/20/2005WO2005098025A2 High throughput reactive oxygen species-based cytochrome p450 inhibition assay
10/20/2005WO2005098024A1 In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes
10/20/2005WO2005098023A1 Microbial growth assay
10/20/2005WO2005098022A1 Bacteria counting method and bacteria counter
10/20/2005WO2005098021A1 Detecting targets using nucleic acids having both a variable region and a conserved region
10/20/2005WO2005098020A1 Assay method for determining mucosal neutrophil counts in neutropenia patients
10/20/2005WO2005098019A2 Method and device for testing the bactericidal effect of substances
10/20/2005WO2005097993A2 Immunostimulatory viral rna oligonucleotides
10/20/2005WO2005097989A1 Method of detecting and quantifying wheat endogenous dna sequence
10/20/2005WO2005097970A1 Protein chip having immobilized ubiquitin-conjugating enzymes
10/20/2005WO2005097968A1 Microbe detector and method of microbe detection
10/20/2005WO2005097818A2 An assay system for screening protease inhibitors
10/20/2005WO2005097421A2 Methods for identifying risk of osteoarthritis and treatments thereof
10/20/2005WO2005097189A1 Carcinoma cell-specific apoptosis inducing agent targeting gene relevant to chromosome stabilization
10/20/2005WO2005096781A2 Methods and compositions for treating gain-of-function disorders using rna interference
10/20/2005WO2005096693A2 Cancer prognosis and/or diagnosis method
10/20/2005WO2005083117A3 A novel dna marker for drought tolerance in plants
10/20/2005WO2005079173A3 A plynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide
10/20/2005WO2005078122A3 Method for enrichment involving elimination by mismatch hybridisation
10/20/2005WO2005075677A3 Identification of compounds susceptible to induce pidd in cells lacking p53 and their use in combination with genotoxins for the treatment of cancer
10/20/2005WO2005075661A3 Method for testing or screening for an enzyme of interest
10/20/2005WO2005073404A3 Functional element of siah-1b responsive p53
10/20/2005WO2005068647A3 Methods for detecting bacterial pathogens
10/20/2005WO2005061735A3 Strand-specific amplification
10/20/2005WO2005059162A9 Microbial detection and quantification
10/20/2005WO2005057176A3 Method for identification of enzymes
10/20/2005WO2005052189A3 Method for hla typing
10/20/2005WO2005049863A3 Identification of diagnostic markers for communicable subacute spongiform encephalopathies
10/20/2005WO2005049800A3 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
10/20/2005WO2005045205A3 Combinatorial lubricating oil composition libraries
10/20/2005WO2005045070A3 Method for prognosticating a breast cancer
10/20/2005WO2005040180A3 Antisense modulation of superoxide dismutase 1, soluble (sod-1) expression
10/20/2005WO2005038052A3 Method for identifying interferon mimics
10/20/2005WO2005035760A3 Molecular nanomotor
10/20/2005WO2005031005A3 Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005WO2005020794A3 Taxane chemosensitivity prediction test
10/20/2005WO2005010142A8 Plant centromere compositions
10/20/2005WO2005005952A3 Electrocatalytic nucleic acid hybridization detection